Literature DB >> 18498135

Predictors of ovarian cancer survival: a population-based prospective study in Sweden.

Ling Yang1, Asa Klint, Mats Lambe, Rino Bellocco, Tomas Riman, Kjell Bergfeldt, Ingemar Persson, Elisabete Weiderpass.   

Abstract

Ovarian cancer is the leading cause of death from gynecologic malignancies among women worldwide. Little is known about reproductive factors or lifestyle determinants and ovarian cancer prognosis. The objective of this study was to examine whether ovarian cancer survival is influenced by reproductive history, anthropometric characteristics, prediagnostic life-style factors and family history of breast or ovarian cancer. The study population consisted of 635 epithelial ovarian cancer (EOC) cases derived from a nationwide population-based case-control study conducted in Sweden between 1993 and 1995. Exposure data on prediagnostic factors of interest were collected through questionnaires at the beginning of the parent study. Clinical data were abstracted from medical records. Cases were followed-up by means of record linkage to nationwide registers until December 31, 2002. Cox proportional hazard regression model was used to estimate the prognostic effect of each factor in terms of hazard ratios (HR) and 95% confidence intervals (CI), following adjustment for age at diagnosis, FIGO tumor stage and WHO grade of tumor differentiation. Tumor characteristics significantly influenced the risk of death from EOC. After adjustment for these, no clear associations were detected between reproductive history (parity, age at first or last birth, oral contraceptive use, age at menarche or menopause), anthropometric characteristics (body size and shape in different periods of life), lifestyle factors before diagnosis (alcohol consumption, smoking and physical activity over lifetime), nor family history of breast cancer or ovarian cancer and EOC survival. Our findings indicate that these prediagnostic factors do not influence the EOC survival. Nevertheless, among women with early stage disease (FIGO stage I and II), there was some indication that overweight in young adulthood or recent years increased the risk of death, while physical activity in young adult life appeared to reduce the risk of death due to EOC.

Entities:  

Mesh:

Year:  2008        PMID: 18498135     DOI: 10.1002/ijc.23429

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

Review 1.  Epithelial ovarian cancer and recreational physical activity: A review of the epidemiological literature and implications for exercise prescription.

Authors:  Rikki A Cannioto; Kirsten B Moysich
Journal:  Gynecol Oncol       Date:  2015-03-20       Impact factor: 5.482

2.  Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.

Authors:  Camilla Praestegaard; Allan Jensen; Signe M Jensen; Thor S S Nielsen; Penelope M Webb; Christina M Nagle; Anna DeFazio; Estrid Høgdall; Mary Anne Rossing; Jennifer A Doherty; Kristine G Wicklund; Marc T Goodman; Francesmary Modugno; Kirsten Moysich; Roberta B Ness; Robert Edwards; Keitaro Matsuo; Satoyo Hosono; Ellen L Goode; Stacey J Winham; Brooke L Fridley; Daniel W Cramer; Kathryn L Terry; Joellen M Schildkraut; Andrew Berchuck; Elisa V Bandera; Lisa E Paddock; Leon F Massuger; Nicolas Wentzensen; Paul Pharoah; Honglin Song; Alice Whittemore; Valerie McGuire; Weiva Sieh; Joseph Rothstein; Hoda Anton-Culver; Argyrios Ziogas; Usha Menon; Simon A Gayther; Susan J Ramus; Alexandra Gentry-Maharaj; Anna H Wu; Celeste L Pearce; Malcolm Pike; Alice W Lee; Rebecca Sutphen; Jenny Chang-Claude; Harvey A Risch; Susanne K Kjaer
Journal:  Int J Cancer       Date:  2017-01-24       Impact factor: 7.396

3.  A randomized parallel-group dietary study for stages II-IV ovarian cancer survivors.

Authors:  Raheem J Paxton; Celia Garcia-Prieto; Maria Berglund; Mike Hernandez; Richard A Hajek; Beverly Handy; Jubilee Brown; Lovell A Jones
Journal:  Gynecol Oncol       Date:  2011-11-23       Impact factor: 5.482

4.  Clinicodemographic factors influencing outcomes in patients with low-grade serous ovarian carcinoma.

Authors:  Matthew P Schlumbrecht; Charlotte C Sun; Karen N Wong; Russell R Broaddus; David M Gershenson; Diane C Bodurka
Journal:  Cancer       Date:  2011-02-11       Impact factor: 6.860

5.  Recreational physical activity and ovarian cancer risk and survival.

Authors:  Patricia G Moorman; Lee W Jones; Lucy Akushevich; Joellen M Schildkraut
Journal:  Ann Epidemiol       Date:  2011-03       Impact factor: 3.797

6.  Pre- and post-diagnosis body mass index, weight change, and ovarian cancer mortality.

Authors:  Yang Zhou; Melinda L Irwin; Harvey A Risch
Journal:  Gynecol Oncol       Date:  2010-11-23       Impact factor: 5.482

7.  In vitro extreme drug resistance assay to taxanes or platinum compounds for the prediction of clinical outcomes in epithelial ovarian cancer: a prospective cohort study.

Authors:  Hee Seung Kim; Tae Joong Kim; Hyun Hoon Chung; Jae Weon Kim; Byung Gie Kim; Noh Hyun Park; Yong Sang Song; Duk Soo Bae; Soon Beom Kang
Journal:  J Cancer Res Clin Oncol       Date:  2009-05-16       Impact factor: 4.553

8.  Expression of cofilin 1 is positively correlated with the differentiation of human epithelial ovarian cancer.

Authors:  Jianwei Zhou; Yinfen Wang; Jing Fei; Weijiang Zhang
Journal:  Oncol Lett       Date:  2012-09-06       Impact factor: 2.967

9.  Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness.

Authors:  Elizabeth M Poole; Melissa A Merritt; Susan J Jordan; Hannah P Yang; Susan E Hankinson; Yikung Park; Bernard Rosner; Penelope M Webb; Daniel W Cramer; Nicolas Wentzensen; Kathryn L Terry; Shelley S Tworoger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-10       Impact factor: 4.254

Review 10.  Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review.

Authors:  Rachel Ballard-Barbash; Christine M Friedenreich; Kerry S Courneya; Sameer M Siddiqi; Anne McTiernan; Catherine M Alfano
Journal:  J Natl Cancer Inst       Date:  2012-05-08       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.